| 000 | 01684 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250518003314.0 | ||
| 264 | 0 | _c20190522 | |
| 008 | 201905s 0 0 eng d | ||
| 022 | _a1744-6880 | ||
| 024 | 7 |
_a10.1097/FPC.0000000000000355 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSood, Nikita | |
| 245 | 0 | 0 |
_aLeveraging electronic health records to assess the role of ADRB2 single nucleotide polymorphisms in predicting exacerbation frequency in asthma patients. _h[electronic resource] |
| 260 |
_bPharmacogenetics and genomics _c11 2018 |
||
| 300 |
_a256-259 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAdrenal Cortex Hormones _xadverse effects |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAlleles |
| 650 | 0 | 4 |
_aAsthma _xgenetics |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aElectronic Health Records |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Frequency |
| 650 | 0 | 4 | _aGenetic Predisposition to Disease |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHeterozygote |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPharmacogenetics |
| 650 | 0 | 4 |
_aPolymorphism, Single Nucleotide _xgenetics |
| 650 | 0 | 4 |
_aReceptors, Adrenergic, beta-2 _xgenetics |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aConnolly, John J | |
| 700 | 1 | _aMentch, Frank D | |
| 700 | 1 | _aVazquez, Lyam | |
| 700 | 1 | _aSleiman, Patrick M A | |
| 700 | 1 | _aHysinger, Erik B | |
| 700 | 1 | _aHakonarson, Hakon | |
| 773 | 0 |
_tPharmacogenetics and genomics _gvol. 28 _gno. 11 _gp. 256-259 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/FPC.0000000000000355 _zAvailable from publisher's website |
| 999 |
_c28952672 _d28952672 |
||